Stop Unfair Medicaid Recoveries Act
Summary
The Stop Unfair Medicaid Recoveries Act (HR6951) has been introduced in the House and referred to committee. It would ban Medicaid estate recovery and mandate withdrawal of related liens, but is in early stages with no funding or direct impact on public companies. No directly affected publicly traded companies or investable sectors are identifiable from the bill text alone.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR6951 has no direct market impact—it does not authorize spending, contracts, or tax incentives.
- 2.No publicly traded company's primary revenue stream is affected by ending Medicaid estate recovery.
- 3.The bill is early-stage with 22 Democratic cosponsors and no companion in the Senate.
Market Implications
No market implications are identifiable. The bill's mechanism is purely administrative (state estate recovery rules) with no procurement, tax credit, or regulatory market impact. No tickers meet the confidence threshold for inclusion.
Full Analysis
-
What happened: On 2026-01-06, Rep. Schakowsky (D-IL) introduced HR6951, the Stop Unfair Medicaid Recoveries Act. The bill was referred to the House Committee on Energy and Commerce. It currently has 22 cosponsors, all Democrats, and is in early legislative stages.
-
The money trail: The bill does not authorize or appropriate any federal spending. Its text amends the Social Security Act to prohibit state Medicaid programs from using estate recovery for cost recoupment and requires withdrawal of existing liens within 90 days. This is a regulatory change affecting state Medicaid administration, not federal procurement or market funding.
-
Structural winners and losers: The bill primarily affects state governments and Medicaid beneficiaries, not publicly traded companies. No public company's revenue, costs, or competitive position is directly altered by ending estate recovery. Estate recovery is a post-death collection mechanism with no material impact on drug pricing, insurance premiums, or provider reimbursement models.
-
Competitive landscape: No tickers have a causal chain meeting the 0.65 confidence threshold. The bill does not create contracts, tax incentives, or regulatory changes that flow through to public markets.
-
Timeline: The bill is in early stage—referred to one committee. To become law, it must pass committee, House floor, Senate (no companion bill identified), and be signed by the President. No further actions recorded as of the latest data. Legislative probability is low given partisan sponsor and no Republican cosponsors.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Executive Order: Promoting Efficiency, Accountability, and Performance in Federal Contracting
Executive Order: Accelerating Medical Treatments for Serious Mental Illness
ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
Protecting Health Care and Lowering Costs Act of 2025
Executive Order: Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
Veterans SPORT Act
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $1.1B Department of Veterans Affairs Contract
Consolidated Appropriations Act, 2026
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.